Amit Alfasi, Author at Peregrine

Restore Medical

Restore Medical secures $23 million Series B; two global strategics join the round

Merck, Incentive, Incubator

Merck joins Incentive incubator as strategic partner

ClearMargin

IonaraBio

Lutris Pharma

start up nation Most active investor 2024 Healthcare

Peregrine Ventures recognized as Israel’s most active healthtech investor

Endostream Kaneka

EndoStream Medical acquired by Kaneka corporation

Bio ReFine™ achieves First-in-Human success with Coriofix™ system

Momentis Surgical™ achieves two FDA clearances in two weeks

Nectin Therapeutics Secures Global License Agreement with Immunome, Inc.

Nectin Therapeutics secures global license agreement with Immunome, Inc.